RecruitingNCT07568561

Maternal Methyl-Nutrient Status and Infant Neurodevelopment Study

Maternal Methyl-Nutrient Status During Pregnancy and Its Association With Infant Neurodevelopment: Exploring Potential Mechanisms

Sponsor

Far Eastern Memorial Hospital

Enrollment

240 participants

Start Date

May 27, 2026

Study Type

OBSERVATIONAL

Conditions

Pregnancy Nutrition Dietary Quality Homocysteine Birth Outcomes Dietary Intake Assessment Infant Neurodevelopment Methylation Trimethylamine N-oxide (TMAO)

Summary

This prospective cohort study examines the relationship between maternal methyl-nutrient status during pregnancy and offspring neurodevelopment. It integrates maternal dietary, biomarker, genetic, and microbiome data and follows children up to 24 months.

Eligibility

Min Age: 0 DaysMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with birth outcomes, dietary intake assessment, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 0 Days to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.